SCHEMBL4298623

SCHEMBL4298623

C=CC(C1=NCCN1)C(C)O

nearest known ligand 0.41

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 5/20 0.41
MAOA P21397 4/20 0.41
MAOB P27338 4/20 0.41
ADRA2B P18089 10/20 0.41
ADRA2C P18825 10/20 0.41
ADRA2A P08913 9/20 0.40
HTR1A P08908 2/20 0.39
KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7135197 0.98 NISCH (0.41) NISCHMAOAMAOBADRA2BADRA2C
SCHEMBL1992259 0.84 ADRA2B (0.36) NISCHMAOAMAOBADRA2BADRA2C
SCHEMBL4912194 0.82 ADRA2B (0.43) NISCHMAOAMAOBADRA2BADRA2C
SCHEMBL3264669 0.77
SCHEMBL9754198 0.77 ADRA2B (0.38) NISCHMAOAMAOBADRA2BADRA2C
SCHEMBL1326510 0.76 ADRA2B (0.38) NISCHMAOAMAOBADRA2BADRA2C
SCHEMBL25143431 0.74
SCHEMBL947803 0.74
SCHEMBL9439738 0.70
SCHEMBL1768228 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1357067-A Antistats for high temp short heater texturing ORGNESS CORP (US) 2002-07-03 CN claimed
US-5342961-A Process for the production of low-viscosity imidazolinium surfactants by quaternization of 1-hydroxyethyl-2-alkyl imidazolines HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1994-08-30 US claimed
US-4567132-A Multi-level resist image reversal lithography process INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1986-01-28 US claimed
JP-3186305-A None JP disclosed
US-20230286924-A1 CRYSTALLINE FORMS OF 4-(7-HYDROXY-2-ISOPROPYL-4-OXO-4H-QUINAZOLIN-3-YL)-BENZONITRILE AND FORMULATIONS THEREOF CITIBANK, N.A., AS NOTES COLLATERAL AGENT 2023-09-14 US disclosed
CN-111568906-B Formulations of 4- (7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl) -benzonitrile 诺华股份有限公司 2023-09-01 CN disclosed
CN-116648670-A Method for manufacturing light-emitting device and light-emitting device 夏普株式会社 2023-08-25 CN disclosed
CN-116419918-A Crystalline forms of 4- (7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl) -benzonitrile and formulations thereof 诺华股份有限公司 2023-07-11 CN disclosed
EP-4192466-A1 CRYSTALLINE FORMS OF 4-(7-HYDROXY-2-ISOPROPYL-4-OXO-4H-QUINAZOLIN-3-YL)-BENZONITRILE AND FORMULATIONS THEREOF Novartis AG (CH) 2023-06-14 EP disclosed
US-20230139170-A1 Formulations of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT 2023-05-04 US disclosed
US-11584829-B2 Methods for preparing waterborne heat seal coating compositions DOW GLOBAL TECHNOLOGIES LLC (US) 2023-02-21 US disclosed
EP-0216955-A1 Method for preparing an electrolyte solution for electroplating tin or tin-lead alloys LeaRonal, Inc. (US) 1987-04-08 EP disclosed
US-4617097-A Process and electrolyte for electroplating tin, lead or tin-lead alloys LEARONAL, INC. (US) 1986-10-14 US disclosed
US-4567132-A Multi-level resist image reversal lithography process INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1986-01-28 US disclosed
EP-0164248-A2 Photosensitive coating compositions, thermally stable coatings prepared from them, and the use of such coatings in forming thermally stable polymer images ROHM AND HAAS COMPANY (US) 1985-12-11 EP disclosed
US-4503002-A CATIONIC SURFACTANTS MONA INDUSTRIES, INC. (US) 1985-03-05 US disclosed
US-4293097-A Method for brightening natural calcitic ores ANGLO-AMERICAN CLAYS CORPORATION (US) 1981-10-06 US disclosed
US-4124632-A AMPHOTERIC COMPOUNDS WITH TWO BASIC GROUPS, ONE OF WHICH IS QUATERNARY AMMONIUM, AND A CARBOXYLIC ANIONIC GROUP SOCIETE ANONYME DITE L'OREAL (FR) 1978-11-07 US disclosed
US-4104070-A Method of making a negative photoresist image INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1978-08-01 US disclosed
US-4020155-A AMPHOTERIC COSMETIC SOCIETE ANONYME DITE: L'OREAL (FR) 1977-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230139170-A1 Formulations of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile HRH4, AQP4, P2RY4 NISCH 143/4885MAOA 2071/4885MAOB 2076/4885
US-20230286924-A1 CRYSTALLINE FORMS OF 4-(7-HYDROXY-2-ISOPROPYL-4-OXO-4H-QUINAZOLIN-3-YL)-BENZONITRILE AND FORMULATIONS THEREOF P2RY4, AQP4, P2RX4 NISCH 238/4885MAOA 1857/4885MAOB 1918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.